Cargando…

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host disease. This article aims to review the current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metafuni, Elisabetta, Di Marino, Luca, Giammarco, Sabrina, Bellesi, Silvia, Limongiello, Maria Assunta, Sorà, Federica, Frioni, Filippo, Maggi, Roberto, Chiusolo, Patrizia, Sica, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536954/ https://www.ncbi.nlm.nih.gov/pubmed/37764025 http://dx.doi.org/10.3390/microorganisms11092182

Ejemplares similares

Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
por: Galli, Eugenio, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center
por: Giammarco, Sabrina, et al.
Publicado: (2023)

Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
por: Sora, Federica, et al.
Publicado: (2021)

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

Epstein-Barr Virus Related Lymphoproliferations After Stem Cell Transplantation
por: Sica, Simona, et al.
Publicado: (2009)

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021)

Days Alive Outside Hospital and Readmissions in Patients Undergoing Allogeneic Transplants from Identical Siblings or Alternative Donors
por: Sora, Federica, et al.
Publicado: (2020)

Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Allogeneic Transplantation for Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2010)

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)

H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016
por: Metafuni, Elisabetta, et al.
Publicado: (2017)

P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL-LIFE EXPERIENCE.
por: Innocenti, Idanna, et al.
Publicado: (2023)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Extending Long Term Follow up of Patient with Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: Disclosing Late Mortality and Causes of Death
por: Sora, F., et al.
Publicado: (2020)

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia
por: Sorà, Federica, et al.
Publicado: (2016)

Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
por: Autore, Francesco, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review
por: Pession, Andrea, et al.
Publicado: (2021)

Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Editorial: The latest advances in transplantation for AML
por: Chiusolo, Patrizia, et al.
Publicado: (2023)

The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
por: Henig, Israel, et al.
Publicado: (2020)

Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors
por: Corbingi, Andrea, et al.
Publicado: (2021)

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria
por: Battipaglia, Giorgia, et al.
Publicado: (2019)

P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE
por: Stirparo, L., et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Gut microbiota and allogeneic transplantation
por: Wang, Weilin, et al.
Publicado: (2015)

Fecal Microbiota Transplantation: Is It Safe?
por: Park, Seon-Young, et al.
Publicado: (2021)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: gut microbiota profiling, infectious and clinical outcomes
por: Merli, Pietro, et al.
Publicado: (2020)

Fecal microbiota transplantation: the state of the art
por: Di Bella, Stefano, et al.
Publicado: (2013)

Fecal Microbiota Transplant: Benefits and Risks
por: Weil, Ana A., et al.
Publicado: (2015)

Clinical Usefulness of Fecal Microbiota Transplantation
por: Park, Jung Ho
Publicado: (2017)

Fecal Microbiota Transplantation in Neurological Disorders
por: Vendrik, Karuna E. W., et al.
Publicado: (2020)

Next Generation Fecal Microbiota Transplantation
por: Gweon, Tae-Geun, et al.
Publicado: (2021)

Fecal microbiota transplantation – where are we?
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e112k1ftgmekjft17g9a01b21b